|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/14 | |
| A61K 31/675 | |||
| A61P 31/04 |
| (11) | Number of the document | 2393808 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10703403.5 |
| Date of filing the European patent application | 2010-02-03 | |
| (97) | Date of publication of the European application | 2011-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/023122 |
| Date | 2010-02-03 |
| (87) | Number | WO 2010/091131 |
| Date | 2010-08-12 |
| (30) | Number | Date | Country code |
| 149402 P | 2009-02-03 | US |
| (72) |
PHILLIPSON, Douglas, US
REICHENBACHER, Katharina, CH
DUGUID, Robert J., US
WARE, Jacqueline, A., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | CRYSTALLINE FORM OF R)-3-(4-(2-(2-METHYLTETRAZOL-5-YL)PYRIDIN-5-YL)-3-FLUOROPHENYL)-5-HYDROXYMETHYL OXAZOLIDIN-2-ONE DIHYDROGEN PHOSPHATE |
| CRYSTALLINE FORM OF R)-3-(4-(2-(2-METHYLTETRAZOL-5-YL)PYRIDIN-5-YL)-3-FLUOROPHENYL)-5-HYDROXYMETHYL OXAZOLIDIN-2-ONE DIHYDROGEN PHOSPHATE |